Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
177M
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
10.7M
-
Shares change
-
+5.68M
-
Total reported value, excl. options
-
$449M
-
Value change
-
+$241M
-
Number of buys
-
43
-
Number of sells
-
-11
-
Price
-
$41.98
Significant Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q1 2015
57 filings reported holding OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share as of Q1 2015.
OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.7M shares
of 177M outstanding shares and own 6.04% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (2.08M shares), Polaris Venture Management Co. V, L.L.C. (2.03M shares), FMR LLC (1.37M shares), WELLINGTON MANAGEMENT GROUP LLP (1.22M shares), Capital World Investors (799K shares), Lamond Capital Partners LLC (420K shares), RS INVESTMENT MANAGEMENT CO LLC (408K shares), FEDERATED INVESTORS INC /PA/ (228K shares), Ballentine Partners, LLC (210K shares), and Pentwater Capital Management LP (200K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.